Abstract
Background:
Substance use has been extensively linked to sexual behavior and HIV/STI risk among men who have sex with men (MSM) and transgender women (TW). However, the impact of specific substances and on specific partnership types is not well characterized. The current study seeks to estimate the association between specific substances and partnership rates while carefully disaggregating between and within-person associations to characterize the nature of these associations and inform prevention interventions.
Methods:
Using data from a longitudinal cohort (n = 1,159) of young MSM (YMSM) and young TW (YTW), we utilized a series of hybrid mixed effect models to estimate the associations between substance use (i.e., heavy episodic drinking [HED], marijuana, cocaine, ecstasy, methamphetamine, poppers, prescription stimulant, prescription painkiller, and prescription depressants) and partnerships (i.e., one-time, casual, and main).
Results:
Results from multivariable models indicated people using substances had higher one-time (HED, poppers) and casual (HED, methamphetamine, poppers) partnership rates. In addition, participants reported higher rates of one-time (HED, ecstasy, methamphetamine, poppers) and casual partners (HED, marijuana, cocaine, methamphetamines, poppers) during periods of substance use.
Conclusion:
These findings confirm that the highest rates of sexual activity occur among YMSM-YTW using substances during periods of substance use. Yet, these findings should caution researchers against simplistic generalizations as these associations differ across substance and partnership types. Efforts to promote the health of MSM-YTW who use substances should carefully consider this complexity as interventions accounting for the unique cultural context of substance use in these populations are most likely to be successful.
1. Introduction
Men who have sex with men (MSM) and transgender women (TW) continue to experience high HIV incidence rates (CDC, 2022), with highest risk among young MSM (YMSM) and young TW (YTW) (Jeffries et al., 2018; McFarland et al., 2020; Mustanski et al., 2019b). Drug and alcohol use are also elevated among YMSM (Schuler et al., 2018) and YTW (Connolly and Gilchrist, 2020) and this substance use has been associated with the acquisition of HIV and other sexually transmitted infections (Baliunas et al., 2010; Sander et al., 2013; Tomkins et al., 2019; Vu et al., 2015). For example, one-in-three HIV infections among a cohort of sexual and gender minorities who have sex with men occurred among individuals who persistently used methamphetamine and was associated with four to seven times the odds of seroconversion (Grov et al., 2020). Similarly, strong associations between methamphetamine or cocaine use and HIV risk have been observed among TW (Reback and Fletcher, 2014). However, the specific causal mechanisms driving these associations are complex and not yet fully understood (Melendez-Torres and Bourne, 2016).
One mechanism may be that individuals who are under the influence of substances are more likely to engage in sexual risk (e.g., condomless sex), which then increases likelihood of HIV acquisition (Melendez-Torres and Bourne, 2016; Shen et al., 2022). This is particularly true for people who use alcohol and/or amphetamines (Vosburgh et al., 2012). For example, intoxicating doses of alcohol can increase the likelihood of engaging in condomless sex (Berry and Johnson, 2018; George, 2019; Palfai and Luehring-Jones, 2021). Experimental studies suggest rates of condomless sex among individuals using these substances may reflect increased sexual desire, disinhibition, and the impact on decision making such as delay discounting (Berry et al., 2020; Johnson et al., 2020; Rehm et al., 2012).
As noted by Vosburgh (2012), most studies examining the relationship between substance use and sexual risk focus on condomless sex acts (Aguilera-Mijares et al., 2021; Schlissel et al., 2022; Vosburgh et al., 2012) because this is the most proximal HIV/STI sexual risk behavior. Yet, in addition to decreasing the likelihood of condom use within a given sexual encounter, substance use may also increase the rate of sexual encounters (Wray et al., 2020). For example, increased sexual arousal from substances such as methamphetamine and cocaine (Berry et al., 2020; Johnson et al., 2017) may increase the likelihood of a sexual encounter. Event-level studies of MSM indicate a higher likelihood of a sexual encounter on days in which participants used substances (Rendina et al., 2015). Yet, the number of sexual encounters alone provides limited information regarding HIV/STI risk, as encounters with new versus existing partners will differentially impact risk. For example, substance use may differential impact sexual behavior with new versus repeat partners (Janulis et al., 2018; Maisto et al., 2021; Newcomb and Mustanski, 2014) as the impact of substance use on decision making may vary according to partnership characteristics such as trust and communication (Newcomb, 2020).
The number of new partners (i.e., partnership acquisition rate) also provides important information regarding the likelihood of novel exposure to STIs (Garnett et al., 2008; Romero-Severson et al., 2015). However, event and daily diary studies rarely distinguish the impact of substance use on partnership rates because they do not differentiate between sexual encounters with new versus existing partners. Studies directly examining the impact of substance use on the number of partners have generally found that participants who use substances have a higher number of sexual partners compared to those who do not (Chas et al., 2021; Jalil et al., 2022; Moradi et al., 2022; Rosenberg et al., 2011; Wray et al., 2020). For example, a meta-analysis indicated that that MSM using methamphetamine were 3.7 times more likely to have multiple casual sex partners compared to MSM not using methamphetamine (Moradi et al., 2022). However, most studies in this meta-analysis focused on between-person differences in substance use and partnership rates, often with cross-sectional data, and rarely utilized statistical methods that distinguished within and between-person associations. That is, while many studies have observed that individuals who use substances report more sexual partners (i.e., between-person) only a small subset have examined if the same individuals report more sexual partners during periods of substance use (i.e., within-person). In addition, many studies also aggregate substances into categories (e.g., ‘club drugs’ for all stimulants) due to the relatively infrequent use of some substances despite important differences in the properties of these substances and social contexts in which they are used (Vosburgh et al., 2012). In addition, few studies carefully distinguish between types of partnerships (e.g., main, persistent casual, one-time) despite the impact partnership type has on associated behaviors (Boyer et al., 2019; Cambou et al., 2014; Mustanski et al., 2011; Sullivan et al., 2009). For example, condomless sex is substantially higher among main partners (Bachman et al., 2021; Bavinton et al., 2017; Newcomb and Mustanski, 2016) and casual partners with longer partnership duration (Bachman et al., 2021; Pines et al., 2017), likely driven by the increased trust among main and long-term casual partners (Mustanski et al., 2014; Prestage et al., 2012; Zablotska et al., 2011).
The purpose of the current study is to quantify the association between specific substances and partnership rates to understand this mechanism linking substance use and HIV/STI risk among YMSM and YTW. To do so, we carefully disaggregate within and between-person associations of substance use and partnership rates using hybrid mixed effect models, leveraging a longitudinal cohort of YMSM-YTW. By doing so, we hope to provide novel estimates of these associations, separately for each partnership type, to inform a more wholistic understanding of the impact of substance use on sexual behavior and to support identification of the characteristics and context of substance use in which YMSM-YTW are at the highest risk for HIV/STIs.
2. Method
2.1. Participants and Procedures
Data from this study come from the RADAR study (Mustanski et al., 2019a, 2019b), a longitudinal cohort study of YMSM-YTW in Chicago. Eligibility for this study included the following criteria: 16 to 29 years old at enrollment, male assigned at birth (including transgender women and other non-cisgender identified individuals), English-speaking, reporting a sexual encounter with a man in the previous year or identifying as gay or bisexual, and the ability to attend in-person research visits in Chicago. Participants were recruited from two prior cohorts, Project Q2 (Mustanski et al., 2010) and Crew 450 (Mustanski et al., 2013), with additional new cohort members recruited via the same methods as the original two studies through venue-based, online, peer, and significant partner recruitment. Additional details of the RADAR cohort can be found elsewhere (Mustanski et al., 2019a). Data for the current analysis comes from the beginning of data collection: February 2015 through March 2020. Following their first visit, participants were eligible for one visit every 6 months. Data from all cohort members with their first visit before March 2020, were included in this study, for a total of 1,159 participants. All data from participants’ first to last eligible visit were included in this study, leading to 9,529 observations representing with mean follow up time 1.92 years. However, item level missing data was present in 460 (4.8%) of visits while there were 1,989 (20.9%) missed visits indicating a completion rate of 79.1%. Missing data was more common in white than Black participants, and at study visits after the second visit.
2.2. Measures
A comprehensive network inventory of social, sexual, and drug use partners was conducted at each study visit. During this interview, a ‘name generator’ was used to elicit all sexual partners in the past 6-months. Following this elicitation, participants privately provided detailed information in a survey on each sexual partner, including the number of anal sex acts, number of condomless anal sex acts, main partner status, and dates of first and last sex.
The main outcome variables of the current analysis were based on classification of anal sex partners as one of three types: main, casual, and one-time. This distinction in partner types is common in similar studies (Bachman et al., 2021; Siegler et al., 2013; Spicknall et al., 2022), motivated by differences in levels of risk behavior across types (e.g., likelihood of condom use). Main partners included any partner that the participant indicated they were “currently in a serious relationship.” Partners where sex occurred on more than one day were defined as casual partners, excluding main partners. Finally, one-time partners were those the participant indicated the same first and last date of sex. For the outcome variables, casual and one-time partnership counts, reflect the cumulative number of each type in the 6 months before the study visit. For main partners, a dichotomous indicator was used to indicate the presence or absence of at least one main partner, given the rarity of reporting more than one main partner (0.6%).
Substance use was measured during the computer-assisted psychosocial self-interview. Past 6-month use of the following substances was included in our analysis: heavy episodic drinking (HED), marijuana, cocaine/crack, ecstasy, methamphetamine, poppers (i.e., inhaled nitrites), prescription stimulant or amphetamines, prescription pain killers, and prescription depressants and tranquilizers. HED was indicated if participants responded greater than never to the following question: “How often do you have six or more drinks on one occasion?” The use of each prescription drug was only included if it was not prescribed by a doctor. All dichotomous indicators for substance use were subsequently used to separately examine within and between-person substance use, as described below.
Finally, demographic variables were included as control variables in multivariable models. Demographic data were collected at baseline during the self-administered interview and included age, race/ethnicity (i.e., non-Hispanic Black, non-Hispanic White, Hispanic/Latino, and Other), and gender identity (i.e., Cisgender Male, Transgender Female, or Other). Finally, HIV status was also included as a control variable in all multivariable models. HIV status was determined from screening at their previous study visit or self-reported HIV-positive test result since the last visit. Therefore, HIV status reflects the participant’s perceived status during the period in which behavior was reported (i.e., the 6 months preceding the study visit). HIV status was determined using Alere Determine 4th-Generation HIV-1/HIV-2 Ab/Ag Combo test with confirmatory testing conducted according to CDC guidance (Branson et al., 2014). HIV positive participants that had seen an HIV care provider were asked to indicate “What was the result of your most recent viral load test?” This response was used to code for perceived detectable and undetectable viral load. Finally, PrEP status was measured by determined for HIV negative participants by asking, “In the past 6 months, have you taken any pre-exposure prophylaxis (PrEP) medication such as Truvada or Descovy to reduce your risk of HIV transmission?”
2.3. Analysis
Hybrid random effects models (Falkenström et al., 2017) were used to disaggregate the between and within-person associations between each substance and each partnership type (i.e., main, casual, one-time). Hybrid mixed effect models include person-mean centered (i.e., within) and person-mean (i.e., between) to estimate the within and between-person association between each exposure variable (i.e., substance use) and dependent variable (i.e., partnerships). Between-person (i.e., person-mean) substance use was calculated by assigning the mean of each substance use observation across all observations for the given participant while within-person substance use was calculated by subtracting this person-mean from each individual observation for the given participant. Because all substance use was coded dichotomously (i.e., 0 or 1), these coefficients estimated the difference in partnership rates (casual and one-time), or likelihood of having a main partner, during periods of using or not using each substance (i.e., within-person), as well as the difference between individuals who used or did not use each substance (i.e., between-person). For each outcome, within and between substance use variables were first examined in a series of models looking individually at each single substance (i.e., ‘bivariate’ models than include both within and between effects for a single substance) and then examined in a model examining the effects of all substances simultaneously. As noted, demographic variables, HIV status, and PrEP use were included as controls in multivariable models. We also provide stratified analysis for MSM and TW as supplemental material, given the potential for effect modification across gender identities, although we were focus primarily on the combined results.
For all models, multiple imputation was utilized to account for 25.7% of visits with any missing data in dependent or independent variables. Specifically, multiple imputation by chained equations using predictive mean matching was used for count variables and logistic regression was used for dichotomous variables (Enders et al., 2016). All results are presented as aggregate models using standard procedures to estimate averaged parameters and standard errors (Rubin, 1987). Models for one-time partners and casual partners used a negative binomial distribution while models or main partners used a binomial distribution.
3. Results
Table 1 presents demographic characteristics and descriptive statistics of the cohort. Participants were predominantly non-Hispanic Black/African American (34.1%) and Hispanic/Latino (29.5%), with a mean age of 21.5 years at their first visit. Marijuana was the most used substance, with 88.7% of participants reporting use during at least one visit. This was followed by HED (54.7%) and poppers use (38.7%) during at least one visit.
Table 1.
Participant demographics and descriptive statistics
| Mean (SD) | n (%) | |
|---|---|---|
| Participants (n = 1159) | ||
| Age at first visit | 21.5 (3.1) | - |
| Race/Ethnicity | ||
| Black/African American | - | 395 (34.1) |
| White | - | 296 (25.5) |
| Hispanic/Latino | - | 342 (29.5) |
| Other | - | 126 (10.9) |
| Gender Identity | ||
| Cisgender men | - | 1070 (92.3) |
| Transgender women | - | 60 (5.2) |
| Other | - | 29 (2.5) |
| HIV Status | ||
| HIV-positive | - | 141 (12.2) |
| Undetectable viral load | - | 73 (6.3) |
| HIV-negative | - | 1018 (87.8) |
| Recent PrEP use | - | 75 (6.6) |
| Substance Use: At least once | ||
| Heavy episodic drinking | - | 634 (54.7) |
| Marijuana | - | 1028 (88.7) |
| Cocaine | - | 362 (31.2) |
| Ecstasy | - | 315 (27.1) |
| Methamphetamine | - | 92 (7.9) |
| Poppers | - | 448 (38.7) |
| Presc. Stimulant | - | 290 (26.2) |
| Presc. Painkiller | - | 157 (14.1) |
| Presc. Depressant | - | 187 (17.1) |
| Visits (n = 9529) | ||
| Substance Use: Past 6-months | ||
| Heavy episodic drinking | - | 1947 (25.0) |
| Marijuana | - | 5306 (70.3) |
| Cocaine | - | 976 (12.9) |
| Ecstasy | - | 727 (9.6) |
| Methamphetamine | - | 224 (2.9) |
| Poppers | - | 1362 (18.1) |
| Presc. Stimulant | - | 602 (9.0) |
| Presc. Painkiller | - | 272 (4.0) |
| Presc. Depressant | - | 355 (5.4) |
Note. Participant demographics and HIV status reflect baseline data. The total visits represent raw data.
Bivariate and multivariable results for our main exposure variables (i.e., substance use) can be found in Table 2. For bivariate results of the one-time partner models, younger participants [incidence rate ratio (IRR) = 0.93 (95% CI: 0.89, 0.96)], transgender women [IRR = 0.58 (95% CI: 0.37, 0.90)], and participants with HIV [IRR = 0.58 (95% CI: 0.42, 0.81)] had lower rates of one-time partners while Hispanic/Latino participants [IRR = 1.72 (95% CI: 1.38, 2.14)], White [IRR = 2.23 (95% CI: 1.76, 2.84)], other race/ethnicity [IRR = 2.13 (95% CI: 1.55, 2.91)], and participants on PrEP [IRR = 1.40 (95% CI: 1.22, 1.61)] had higher one-time partnership rates. For substance use, within-person HED [IRR = 1.38 (95% CI: 1.21, 1.57)], marijuana use [IRR = 1.18 (95% CI: 1.01, 1.37)], cocaine use [IRR = 1.29 (95% CI: 1.09, 1.53)], ecstasy use [IRR = 1.36 (95% CI: 1.14, 1.61)], methamphetamine use [IRR = 1.53 (95% CI:1.11, 2.11)], and poppers use [IRR = 1.62 (95% CI: 1.40, 1.87)] were associated with higher one-time partnership rates. For between-person use, substances were associated with higher rates of one-time partnerships (Table 2).
Table 2.
Mixed model results for association between exposure variables and partnership rates
| One-time | Casual | Main | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Bivariate IRR [95% CI] | Multivariable aIRR [95% CI] | Bivariate IRR [95% CI] | Multivariable aIRR [95% CI] | Bivariate OR [95% CI] | Multivariable aOR [95% CI] | |
| Within | ||||||
| HED | 1.38 [1.21, 1.57] | 1.30 [1.14, 1.47] | 1.22 [1.11, 1.35] | 1.18 [1.06, 1.30] | 0.94 [0.76, 1.16] | 0.97 [0.79, 1.19] |
| Marijuana | 1.18 [1.01, 1.37] | 1.09 [0.93, 1.27] | 1.20 [1.07, 1.35] | 1.13 [1.01, 1.26] | 1.13 [0.92, 1.38] | 1.15 [0.94, 1.42] |
| Cocaine | 1.29 [1.09, 1.53] | 1.11 [0.94, 1.31] | 1.39 [1.24, 1.56] | 1.21 [1.08, 1.37] | 0.91 [0.71, 1.17] | 0.94 [0.73, 1.20] |
| Ecstasy | 1.36 [1.14, 1.61] | 1.21 [1.01, 1.44] | 1.25 [1.12, 1.40] | 1.07 [0.95, 1.20] | 0.80 [0.60, 1.07] | 0.79 [0.59, 1.07] |
| Methamphetamine | 1.53 [1.11, 2.11] | 1.41 [1.04, 1.92] | 1.57 [1.26, 1.97] | 1.41 [1.13, 1.76] | 0.85 [0.49, 1.46] | 0.83 [0.48, 1.44] |
| Poppers | 1.62 [1.40, 1.87] | 1.51 [1.30, 1.74] | 1.39 [1.24, 1.56] | 1.26 [1.12, 1.40] | 0.85 [0.49, 1.46] | 1.01 [0.77, 1.32] |
| Presc. Stimulant | 1.14 [0.93, 1.39] | 0.97 [0.79, 1.20] | 1.24 [1.10, 1.41] | 1.12 [0.99, 1.27] | 0.93 [0.63, 1.36] | 0.97 [0.65, 1.44] |
| Presc. Painkiller | 1.15 [0.89, 1.48] | 0.89 [0.69, 1.16] | 1.19 [0.99, 1.44] | 1.06 [0.87, 1.28] | 0.93 [0.62, 1.39] | 0.98 [0.64, 1.49] |
| Presc. Depressant | 1.15 [0.89, 1.49] | 1.01 [0.78, 1.30] | 1.23 [1.03, 1.46] | 1.10 [0.92, 1.32] | 1.15 [0.75, 1.78] | 1.27 [0.82, 1.96] |
| Between | ||||||
| HED | 2.01 [1.52, 2.66] | 1.37 [1.04, 1.80] | 1.90 [1.55, 2.34] | 1.35 [1.09, 1.67] | 1.43 [0.99, 2.07] | 1.34 [0.89, 2.02] |
| Marijuana | 1.44 [1.11, 1.88] | 0.96 [0.75, 1.23] | 1.57 [1.29, 1.90] | 1.15 [0.95, 1.39] | 1.58 [1.14, 2.20] | 1.67 [1.18, 2.36] |
| Cocaine | 2.47 [1.78, 3.45] | 1.44 [0.96, 2.16] | 2.43 [1.88, 3.13] | 1.30 [0.94, 1.79] | 0.95 [0.58, 1.54] | 0.52 [0.27, 0.97] |
| Ecstasy | 2.14 [1.45, 3.17] | 0.77 [0.49, 1.22] | 2.33 [1.71, 3.16] | 1.00 [0.70, 1.43] | 1.34 [0.76, 2.36] | 1.43 [0.71, 2.85] |
| Methamphetamine | 2.45 [1.20, 5.01] | 1.22 [0.64, 2.31] | 4.00 [2.40, 6.66] | 2.06 [1.23, 3.45] | 1.15 [0.42, 3.14] | 0.91 [0.34, 2.41] |
| Poppers | 4.33 [3.30, 5.69] | 3.18 [2.37, 4.26] | 3.08 [2.48, 3.83] | 2.18 [1.70, 2.81] | 1.15 [0.42, 3.14] | 1.56 [0.97, 2.51] |
| Presc. Stimulant | 2.91 [1.90, 4.45] | 1.25 [0.80, 1.94] | 2.34 [1.70, 3.23] | 1.18 [0.80, 1.75] | 0.92 [0.50, 1.69] | 0.81 [0.38, 1.71] |
| Presc. Painkiller | 1.93 [1.03, 3.65] | 1.13 [0.57, 2.27] | 2.28 [1.43, 3.61] | 1.13 [0.66, 1.94] | 0.95 [0.35, 2.53] | 1.08 [0.36, 3.27] |
| Presc. Depressant | 1.96 [1.13, 3.41] | 0.60 [0.32, 1.11] | 2.02 [1.34, 3.06] | 0.75 [0.45, 1.25] | 0.81 [0.37, 1.80] | 0.72 [0.29, 1.81] |
Note. All multivariable models control for age, race/ethnicity, gender identity, HIV status, undetectable viral load, and PrEP use. HED = heavy episodic drinking.
For bivariate results of the casual partner models, participants of other genders [IRR = 0.58 (95% CI: 0.35, 0.96)] had lower rates of casual partners, while White [IRR = 1.31 (95% CI: 1.10, 1.57)], other race/ethnicity [IRR = 1.35 (95% CI: 1.06, 1.72)], and participants on PrEP [IRR = 1.50 (95% CI: 1.37, 1.65)] had higher one-time partnership rates. For within-person substance use, all substances except prescription painkillers were associated with greater numbers of casual partners. For between-person substance use, all substances were associated with higher rates of casual partnerships (Table 2).
For bivariate results of the main partner models, older participants were more likely to have a serious parter [OR = 1.08 (95% CI: 1.03, 1.13)] and the only substance use variable associated with having a main partner were between-person marijuana use [OR = 1.58 (95%CI: 1.14, 2.20)].
Turning to the multivariable results for one-time partners, within-person HED [adjusted IRR (aIRR) = 1.30 (95% CI: 1.14, 1.47)], ecstasy use [aIRR = 1.21 (95% CI: 1.01, 1.44)], methamphetamine use [aIRR = 1.41 (95% CI: 1.04, 1.92)], and poppers use [aIRR = 1.51 (95% CI: 1.30, 1.74)] were associated with greater one-time partnership rates. For between-person results, HED [aIRR = 1.37 (95% CI: 1.04, 1.80)] and poppers use [aIRR = 3.18 (95% CI: 2.37, 4.26)] were associated with greater one-time partnership rates.
For casual partners, within-person HED [aIRR = 1.18 (95% CI: 1.06, 1.30)], marijuana use [aIRR = 1.13 (95% CI: 1.01, 1.26)], cocaine use [aIRR = 1.21 (95% CI: 1.08, 1.37)], methamphetamine use [aIRR = 1.41 (95% CI: 1.13, 1.76)] and poppers use [aIRR = 1.26 (95% CI: 1.12, 1.40)] were associated with greater casual partnership rates. For between-person substance use, HED [aIRR = 1.35 (95% CI: 1.09, 1.67)], methamphetamine use [aIRR = 2.06 (95% CI: 1.28, 3.67)], and poppers use [aIRR = 2.18 (95% CI: 1.70, 2.81)] were associated with greater casual partnership rates.
Finally, for multivariable results of the main partner models, between-person marijuana use [aOR = 1.67 (95% CI: 1.18, 2.36)] and cocaine use [aOR = 0.52 (95% CI: 0.27, 0.97)] were the only independent variable associated with the likelihood of having a main partner.
Given the importance of the within-person results, multivariable person-centered substance use associations with one-time and casual partnership rates are further summarized in Figure 1, which provides a direct visual comparison of the association of each substance with these partnerships. Finally, the stratified analysis indicated results for MSM largely mirrored the combined findings with a noted difference of within-person prescription depressant use being a consistent predictor of one-time and casual partners. However, there were no statistically significant results associations for TW, likely driven by the smaller sample size. While point estimate sometimes mirrored (e.g., HED for casual and one-time partners) and elsewhere differed (e.g., methamphetamine for casual partners) across gender identity, confidence intervals were generally overlapping given the imprecision of estimates for TW.
Figure 1.

Forest plot of within-person associations between substance use behavior and one-time or casual partners in multivariate models.
4. Discussion
Despite substantial accumulated evidence documenting the association between substance use and sexual risk (Scott-Sheldon et al., 2013; Vosburgh et al., 2012), few studies have carefully examined how substance use impacts partnership rates over time across sexual partnership types. As expected, this study found some associations between substance use and all three partnership types. In addition to confirming prior studies indicating substance using MSM had greater numbers of partners (Chas et al., 2021; Moradi et al., 2022; Rosenberg et al., 2011), we demonstrate that within-person substance use is especially tied to higher rates of both one-time partners (HED, ecstasy, methamphetamine, poppers) and casual partners (HED, marijuana, cocaine, methamphetamines, poppers). These findings confirm that the highest rates of sexual activity occur among individuals using substances during periods of substance use, but the magnitude of these associations vary by substance and partnership type.
These results also further clarify the ways in which HIV/STI risk manifests among substance using YMSM and YTW and add to a small body of work examining the likelihood to have sex while using substances (Millar et al., 2018; Rendina et al., 2015) and partnership rates while using these substances (Chas et al., 2021; Moradi et al., 2022; Rosenberg et al., 2011; Wray et al., 2020). In addition, we can be further confident that these associations are not solely driven by higher rates of sexual contact among individuals that use substances by having disaggregated within and between-person associations.
Furthermore, the results indicate that all substances do not have an equal association with partnership rates. While HED, methamphetamine, and poppers use was associated with higher rates of both casual and one-time partners, ecstasy was only associated with higher rates of one-time partners, and marijuana and cocaine were only associated with casual partnerships. Each of these substances has been linked to sexualized drug use, such as ‘chemsex’ or party-n-play (Nambiar, 2023). Although they may represent different types of sexualized drug use with some (e.g., methamphetamine, poppers, cocaine, and MDMA) being very traditional ‘chemsex’ substances used to heighten sexual pleasure and others (e.g., marijuana and alcohol) being commonly used before or during sex, but not necessarily traditionally considered ‘chemsex’ substances (Maxwell et al., 2019; Morgan et al., 2016; Strong et al., 2022). While speculative, the higher level of acceptability among certain substances, such as HED and poppers (Yu and Lasco, 2023), could help explain associations with both one-time and casual partners because relationship dynamics for one-time partners (e.g., trust or intimacy) may differ from casual partners. However, if confirmed, future work is required to better understand these patterns. Nonetheless, these findings provide further nuance to prior studies that have combined several substances (Rendina et al., 2015; Vosburgh et al., 2012).
The observed associations between substance use and sexual partnerships likely also reflect the impact of substance use on sexual arousal, cognition, inhibition, and impulsivity. This is particularly true for substances that have stronger causal evidence of increasing sexual arousal and reducing inhibition, such as alcohol, cocaine, and methamphetamine (Berry et al., 2020; Berry and Johnson, 2018). Therefore, these associations are likely driven by a combination of factors, including substance use leading to more sexual partnerships, the use of substances co-occurring during periods of high sexual activity (Egan et al., 2020), and chemsex/party-n-play where these substances are used specifically to enhance sexual pleasure. It is extraordinarily challenging to accurately estimate the extent to which each of these explanations drive the observed association. Yet, regardless of the causal directions, these findings further emphasize that YMSM-YTW are likely to witness the highest levels of risk during periods using these substances, both in number of partners and number of condomless sex acts, particularly when engaging in HED and poppers use.
Consequently, these findings further highlight the need for tailored interventions for substance using MSM and TW (Elkbuli et al., 2019) including the potential for combined substance use and HIV risk reduction interventions (Cervero-Liceras et al., 2017). Although a minority of MSM engage in chemsex (Maxwell et al., 2019), the strategic use of substances to enhance sexual pleasure cannot be ignored when designing and implementing these interventions, as interventions are only likely to be successful if they account for the unique context of substance use among MSM and TW (Melendez-Torres and Bourne, 2016; Passaro et al., 2019).
The current study had several limitations. First, our stratified analyses were substantially limited by small sample sizes of transgender women. However, the different context of substance use across these populations, such as impact of gender-based discrimination (Hotton et al., 2013; Hughto et al., 2019), certainly warrants attention to potential effect modification of the main associations analyzed in this study. Future studies should further explore how these unique contexts best explain the impact of substance use on sexual behavior and HIV/STI risk across YTW and YMSM. Second, all substance use was measured via self-report despite the known mismatch between biological and self-report measures (Li et al., 2019; Virmani et al., 2022). However, biological measures have considerable variability in windows of detection across substances (Li et al., 2019) and are therefore less feasible across a wide range of substances with an extended time frame to measure behavior (i.e., 6 months). In addition, many of these substances (e.g., methamphetamine) had low prevalence in our sample and may reflect unstable estimates for these associations. Third, we did not have data on sexual positioning for all sexual partners and were therefore unable to differentiate partners where insertive versus receptive anal sex was reported, despite the differential risk these behaviors have for each partner. Fourth, this analysis neither establishes co-occurrence of substance use and sexual encounters nor assesses the temporality of substance use before initiating sexual partnerships. Future studies examining event-level associations that differentiate new versus existing partners could provide further insight but may face alternative challenges such as small frequency of specific types of substance use given the shorter observation time frames that is typical in these studies. Finally, the manuscript is primarily focused on the behavioral associations of substance use with sexual behavior and not the biological outcomes tied to these behaviors (e.g., HIV and other STI acquisition). These outcomes are obviously mediated by additional variables, such as condom use and viral suppression, that must be accounted for when holistically estimating the impact of substance use on HIV/STI risk.
5. Conclusion
This study found within-person substance use was associated with both one-time (HED, ecstasy, methamphetamine, poppers) and casual partners (HED, marijuana, cocaine, methamphetamines, poppers) but not having a main partner. These findings highlight the complexity of the associations between specific substances and sexual behavior among YMSM and YTM and should caution researchers against simplistic generalizations regarding the impact of substance use on HIV/STI risk. The continued effort to disentangle this complexity remains essential to both accurately understanding the impact of substance use on sexual health and designing HIV/STI prevention interventions that appropriately account for the context of substance use in these populations.
Supplementary Material
Highlights.
Substance use and sexual activity are closely linked among MSM and TW
Periods of substance use are associated with greater one-time and casual partners
Drinking, methamphetamine, and popper use are the most consistent correlates
The strength of these associations varies by substance and partnership type
Substance use and partnership rates have complex associations
FUNDING
This work was supported by grants from the National Institute on Drug Abuse (R01DA055502; U01DA036939) and the National Institute of Allergy and Infectious Diseases (R01AI138783) at the National Institutes of Health.
Role of funding source:
This work was supported by grants from the National Institute on Drug Abuse (R01DA055502; U01DA036939) and the National Institute of Allergy and Infectious Diseases (R01AI138783) at the National Institutes of Health.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest: No conflicts to report.
References
- Aguilera-Mijares S, Sang JM, Wang L, Barath J, Card KG, Lachowsky NJ, Lai A, Roth E, Hogg RS, Moore DM, 2021. Variations in sexual behaviors by use of specific substances among Vancouver gay, bisexual, and other men who have sex with men: An event-level analysis. Arch. Sex. Behav 10.1007/s10508-021-02068-8 [DOI] [PubMed] [Google Scholar]
- Bachman VF, Montaño MA, Ulrich A, Villaran M, Cabello R, Gonzalez P, Sanchez H, Lama JR, Duerr A, 2021. Correlates of condomless anal intercourse with different types of sexual partners among men who have sex with men and transgender women in Lima, Peru. AIDS Care 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baliunas D, Rehm J, Irving H, Shuper P, 2010. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int. J. Public Health 55, 159–166. [DOI] [PubMed] [Google Scholar]
- Bavinton BR, Grulich AE, Duncan D, Zablotska IB, Prestage GP, 2017. How partnership type and HIV seroconcordance affect HIV transmission risk in regular sexual partnerships: a cross-sectional survey of Australian gay and bisexual men. Sex. Health 14, 523. [DOI] [PubMed] [Google Scholar]
- Berry MS, Bruner NR, Herrmann ES, Johnson PS, Johnson MW, 2020. Methamphetamine administration dose effects on sexual desire, sexual decision making, and delay discounting. Exp. Clin. Psychopharmacol 10.1037/pha0000398 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berry MS, Johnson MW, 2018. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol. Biochem. Behav 164, 125–138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boyer CB, Greenberg L, Korelitz J, Harper GW, Stewart-Campbell R, Straub D, Sanders R, Reid L-H, Futterman D, Lee S, Ellen JM, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN), 2019. Sexual partner characteristics, relationship type, and HIV risk among a community venue-based sample of urban adolescent and young adult men who have sex with men. Youth Soc. 51, 219–246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Branson BM, Owen SM, Wesolowski LG, Bennett B, Werner BG, Wroblewski KE, Pentella MA, 2014. Laboratory testing for the diagnosis of HIV infection : updated recommendations, 10.15620/cdc.23447 [DOI] [Google Scholar]
- Cambou MC, Perez-Brumer AG, Segura ER, Salvatierra HJ, Lama JR, Sanchez J, Clark JL, 2014. The risk of stable partnerships: associations between partnership characteristics and unprotected anal intercourse among men who have sex with men and transgender women recently diagnosed with HIV and/or STI in Lima, Peru. PLoS One 9, e102894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CDC, 2022. Diagnoses of HIV infection in the United States and dependent areas, 2020 33. [Google Scholar]
- Cervero-Liceras F, Chuah FLH, Ong SE, Murphy G, Balabanova D, Buse K, McKee M, Legido-Quigley H, Haldane VE, 2017. Integrating HIV and Substance Use Services: A Systematic Review. European Journal of Public Health. 10.1093/eurpub/ckx189.042 [DOI] [Google Scholar]
- Chas J, Bauer R, Larabi IA, Peytavin G, Roux P, Cua E, Cotte L, Pasquet A, Capitant C, Meyer L, Raffi F, Spire B, Pialoux G, Molina J-M, Alvarez J-C, 2021. Evaluation of drug abuse by hair analysis and self-reported use among MSM under PrEP: Results from a french substudy of the ANRS-IPERGAY trial. J. Acquir. Immune Defic. Syndr 86, 552–561. [DOI] [PubMed] [Google Scholar]
- Connolly D, Gilchrist G, 2020. Prevalence and correlates of substance use among transgender adults: A systematic review. Addictive Behaviors. 10.1016/j.addbeh.2020.106544 [DOI] [PubMed] [Google Scholar]
- Egan JE, Ho K, Stall R, Drucker MT, Tappin R, Hendrix CW, Marzinke MA, Safren SA, Mimiaga MJ, Psaros C, Elsesser S, Mayer KH, 2020. Feasibility of short-term PrEP uptake for men who have sex with men with episodic periods of increased HIV risk. J. Acquir. Immune Defic. Syndr 84, 508–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elkbuli A, Polcz V, Dowd B, McKenney M, Prado G, 2019. HIV prevention intervention for substance users: a review of the literature. Subst. Abuse Treat. Prev. Policy 14, 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Enders CK, Mistier SA, Keller BT, 2016. Multilevel multiple imputation: A review and evaluation of joint modeling and chained equations imputation. Psychol. Methods 21, 222–240. [DOI] [PubMed] [Google Scholar]
- Falkenström F, Finkel S, Sandell R, Rubel JA, Holmqvist R, 2017. Dynamic models of individual change in psychotherapy process research. J. Consult. Clin. Psychol 85, 537–549. [DOI] [PubMed] [Google Scholar]
- Garnett GP, White PJ, Ward H, 2008. Fewer partners or more condoms? Modelling the effectiveness of STI prevention interventions. Sex. Transm. Infect 84 Suppl 2, ii4–11. [DOI] [PubMed] [Google Scholar]
- George WH, 2019. Alcohol and sexual health behavior: “what we know and how we know it.” J. Sex Res 56, 409–424. [DOI] [PubMed] [Google Scholar]
- Grov C, Westmoreland D, Morrison C, Carrico AW, Nash D, 2020. The crisis we are not talking about: One-in-three annual HIV seroconversions among sexual and gender minorities were persistent methamphetamine users. J. Acquir. Immune Defic. Syndr 85, 272–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hotton AL, Garofalo R, Kuhns LM, Johnson AK, 2013. Substance use as a mediator of the relationship between life stress and sexual risk among young transgender women. AIDS Educ. Prev 25, 62–71. [DOI] [PubMed] [Google Scholar]
- Hughto JMW, Reisner SL, Kershaw TS, Altice FL, Biello KB, Mimiaga MJ, Garofalo R, Kuhns LM, Pachankis JE, 2019. A multisite, longitudinal study of risk factors for incarceration and impact on mental health and substance use among young transgender women in the USA. J. Public Health (Oxf.) 41, 100–109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jalil EM, Torres TS, de A Pereira CC, Farias A, Brito JDU, Lacerda M, da Silva DAR, Wallys N, Ribeiro G, Gomes J, Odara T, Santiago L, Nouveau S, Benedetti M, Pimenta C, Hoagland B, Grinsztejn B, Veloso VG, 2022. High rates of sexualized drug use or chemsex among Brazilian transgender women and young sexual and gender minorities. Int. J. Environ. Res. Public Health 19. 10.3390/ijerph19031704 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Janulis P, Feinstein BA, Phillips G 2nd, Newcomb ME, Birkett M, Mustanski B, 2018. Sexual Partner Typologies and the Association Between Drug Use and Sexual Risk Behavior Among Young Men Who Have Sex With Men. Arch. Sex. Behav 47, 259–271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jeffries WL IV, Greene KM, Paz-Bailey G, McCree DH, Scales L, Dunville R, Whitmore S, 2018. Determinants of HIV incidence disparities among young and older men who have sex with men in the United States. AIDS Behav. 22, 2199–2213. [DOI] [PubMed] [Google Scholar]
- Johnson MW, Herrmann ES, Sweeney MM, LeComte RS, Johnson PS, 2017. Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology 234, 599–612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson MW, Strickland JC, Herrmann ES, Dolan SB, Cox DJ, Berry MS, 2020. Sexual discounting: A systematic review of discounting processes and sexual behavior. Exp. Clin. Psychopharmacol 10.1037/pha0000402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li DH, Janulis P, Mustanski B, 2019. Predictors of correspondence between self-reported substance use and urinalysis screening among a racially diverse cohort of young men who have sex with men and transgender women. Addict. Behav 88, 6–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maisto SA, Simons JS, Palfai TP, Moskal D, Luehring-Jones P, 2021. Daily associations among alcohol intoxication, partner familiarity, participant effortful control, urgency, and PrEP uptake on sexual behavior in men who have sex with men. Arch. Sex. Behav 50, 2843–2860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maxwell S, Shahmanesh M, Gafos M, 2019. Chemsex behaviours among men who have sex with men: A systematic review of the literature. Int. J. Drug Policy 63, 74–89. [DOI] [PubMed] [Google Scholar]
- McFarland W, Wesson P, Turner C, Lin J, Veras M.A. de S.M., Yan H, Raymond HF, Wilson EC, 2020. High HIV incidence among young and racial/ethnic minority transgender women in San Francisco: Results of a longitudinal cohort study. J. Acquir. Immune Defic. Syndr 84, e7–e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melendez-Torres GJ, Bourne A, 2016. Illicit drug use and its association with sexual risk behaviour among MSM: more questions than answers? Curr. Opin. Infect. Dis 29, 58–63. [DOI] [PubMed] [Google Scholar]
- Millar BM, English D, Moody RL, Rendina HJ, Cain D, Antebi-Gruszka N, Carter JA, Parsons JT, 2018. Day-level associations between substance use and HIV risk behavior among a diverse sample of transgender women. Transgend. Health 3, 210–219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moradi S, Moradi Y, Rahmani K, Nouri B, Moradi G, 2022. The association between methamphetamine use and number of sexual partners in men who have sex with men: a systematic review and meta-analysis. Subst. Abuse Treat. Prev. Policy 17, 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morgan E, Skaathun B, Michaels S, Young L, Khanna A, Friedman SR, Davis B, Pitrak D, Schneider J, UConnect Study Team, 2016. Marijuana use as a sex-drug is associated with HIV risk among black MSM and their network. AIDS Behav. 20, 600–607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustanski B, DuBois LZ, Prescott TL, Ybarra ML, 2014. A mixed-methods study of condom use and decision making among adolescent gay and bisexual males. AIDS Behav. 18, 1955–1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustanski B, Garofalo R, Emerson EM, 2010. Mental health disorders, psychological distress, and suicidality in a diverse sample of lesbian, gay, bisexual, and transgender youths. Am. J. Public Health 100, 2426–2432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustanski B, Johnson AK, Garofalo R, Ryan D, Birkett M, 2013. Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men. AIDS Behav. 17, 2173–2179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustanski B, Morgan E, D’Aquila R, Birkett M, Janulis P, Newcomb ME, 2019a. Individual and Network Factors Associated With Racial Disparities in HIV Among Young Men Who Have Sex With Men: Results From the RADAR Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 80, 24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustanski B, Newcomb ME, Clerkin EM, 2011. Relationship characteristics and sexual risk-taking in young men who have sex with men. Health Psychol. 30, 597–605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustanski B, Ryan DT, Newcomb ME, D’Aquila RT, Matson M, 2019b. Very High HIV Incidence and Associated Risk Factors in a Longitudinal Cohort Study of Diverse Adolescent and Young Adult Men Who Have Sex with Men and Transgender Women. AIDS and Behavior, 10.1007/s10461-019-02766-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nambiar D, 2023. A global lens of Party n Play/ Chemsex: mental health and resilience for GBMSM, and cultural and clinically competencies for clinicians working with GBMSM. Popul. Med 5. 10.18332/popmed/164766 [DOI] [Google Scholar]
- Newcomb ME, 2020. Romantic relationships and sexual minority health: A review and description of the Dyadic Health Model. Clin. Psychol. Rev 82, 101924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newcomb ME, Mustanski B, 2016. Developmental change in the effects of sexual partner and relationship characteristics on sexual risk behavior in young men who have sex with men. AIDS Behav. 20, 1284–1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newcomb ME, Mustanski B, 2014. Developmental change in the relationship between alcohol and drug use before sex and sexual risk behavior in young men who have sex with men. AIDS Behav. 18, 1981–1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palfai TP, Luehring-Jones P, 2021. How alcohol influences mechanisms of sexual risk behavior change: Contributions of alcohol challenge research to the development of HIV prevention interventions. AIDS Behav. 10.1007/s10461-021-03346-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Passaro RC, Castañeda-Huaripata A, Gonzales-Saavedra W, Chavez-Gomez S, Segura ER, Lake JE, Cabello R, Clark JL, 2019. Contextualizing condoms: a cross-sectional study mapping intersections of locations of sexual contact, partner type, and substance use as contexts for sexual risk behavior among MSM in Peru. BMC Infect. Dis 19, 958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pines HA, Karris MY, Little SJ, 2017. Sexual partner concurrency among partners reported by MSM with recent HIV infection. AIDS Behav. 21, 3026–3034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prestage G, Jin F, Grulich A, de Wit J, Zablotska I, 2012. Gay men are less likely to use condoms with casual sex partners they know “well.” AIDS Behav. 16, 664–668. [DOI] [PubMed] [Google Scholar]
- Reback CJ, Fletcher JB, 2014. HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach. AIDS Behav. 18, 1359–1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rehm J, Shield KD, Joharchi N, Shuper PA, 2012. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction 107, 51–59. [DOI] [PubMed] [Google Scholar]
- Rendina HJ, Moody RL, Ventuneac A, Grov C, Parsons JT, 2015. Aggregate and event-level associations between substance use and sexual behavior among gay and bisexual men: Comparing retrospective and prospective data. Drug Alcohol Depend. 154, 199–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Romero-Severson EO, Volz E, Koopman JS, Leitner T, lonides EL, 2015. Dynamic Variation in Sexual Contact Rates in a Cohort of HIV-Negative Gay Men. Am. J. Epidemiol 182, 255–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg ES, Sullivan PS, DiNenno EA, Salazar LF, Sanchez TH, 2011. Number of casual male sexual partners and associated factors among men who have sex with men: Results from the National HIV Behavioral Surveillance system. BMC Public Health. 10.1186/1471-2458-11-189 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin DB, 1987. Multiple imputation for survey nonresponse. [Google Scholar]
- Sander PM, Cole SR, Stall RD, Jacobson LP, Eron JJ, Napravnik S, Gaynes BN, Johnson-Hill LM, Bolan RK, Ostrow DG, 2013. Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS 27, 815–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schlissel AC, Carpenter R, Avripas S, Heim Viox M, Johns MM, Harper C, Michaels S, Dunville R, 2022. Substance misuse and condomless sex among transgender youth. Transgend. Health 7, 314–322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schuler MS, Rice CE, Evans-Polce RJ, Collins RL, 2018. Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity. Drug Alcohol Depend. 189, 139–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scott-Sheldon LAJ, Walstrom P, Carey KB, Johnson BT, Carey MP, MASH Research Team, 2013. Alcohol use and sexual risk behaviors among individuals infected with HIV: a systematic review and meta-analysis 2012 to early 2013. Curr. HIV/AIDS Rep 10, 314–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shen Y, Zhang C, Valimaki MA, Qian H, Mohammadi L, Chi Y, Li X, 2022. Why do men who have sex with men practice condomless sex? A systematic review and meta-synthesis. BMC Infect. Dis 22, 850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siegler AJ, Sullivan PS, Khosropour CM, Rosenberg ES, 2013. The role of intent in serosorting behaviors among men who have sex with men sexual partnerships. J. Acquir. Immune Defic. Syndr 64, 307–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spicknall IH, Pollock ED, Clay PA, Oster AM, Charniga K, Masters N, Nakazawa YJ, Rainisch G, Gundlapalli AV, Gift TL, 2022. Modeling the impact of sexual networks in the transmission of Monkeypox virus among gay, bisexual, and other men who have sex with men - United States, 2022. MMWR Morb. Mortal. Wkly. Rep 71, 1131–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strong C, Huang P, Li C-W, Ku SW-W, Wu H-J, Bourne A, 2022. HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men. Lancet HIV 9, e717–e725. [DOI] [PubMed] [Google Scholar]
- Sullivan PS, Salazar L, Buchbinder S, Sanchez TH, 2009. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS 23, 1153–1162. [DOI] [PubMed] [Google Scholar]
- Tomkins A, George R, Kliner M, 2019. Sexualised drug taking among men who have sex with men: a systematic review. Perspect. Public Health 139, 23–33. [DOI] [PubMed] [Google Scholar]
- Virmani I, Oteo A, Dunn M, Vidler D, Roper C, Officer J, Hardy G, Dargan PI, Eddleston M, Cooper JG, Hill SL, Macfarlane R, Keating L, Haden M, Hudson S, Thomas SHL, 2022. Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis. Clin. Toxicol. (Phila.) 1–9. [DOI] [PubMed] [Google Scholar]
- Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW, 2012. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 16, 1394–1410. [DOI] [PubMed] [Google Scholar]
- Vu NTT, Maher L, Zablotska I, 2015. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis. J. Int. AIDS Soc 18, 19273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wray TB, Monti PM, Kahler CW, Guigayoma JP, 2020. Using ecological momentary assessment (EMA) to explore mechanisms of alcohol-involved HIV risk behavior among men who have sex with men (MSM). Addiction 115, 2293–2302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu VG, Lasco G, 2023. Neither legal nor illegal: Poppers as ‘acceptable’ chemsex drugs among men who have sex with men in the Philippines. Int. J. Drug Policy 104004. [Google Scholar]
- Zablotska IB, Grulich AE, De Wit J, Prestage G, 2011. Casual sexual encounters among gay men: familiarity, trust and unprotected anal intercourse. AIDS Behav. 15, 607–612. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
